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Harmful algal blooms are made up of cyanobacteria that can release microcystins (MC’s) into drinking 
water sources, which are toxic to humans. MC’s can be removed during drinking water treatment using 
permanganate pre-oxidation. While permanganate is effective for removing microcystins, it is also non-
specific and has the ability to react with dissolved organic matter (DOM) and cyanobacterial cells that 
exist in the water. Permanganate’s reactions with DOM and cells cause competition for MC-LR removal. 
Additionally, reactions with cells can cause them to lyse and release intracellular MC’s into the water. 
Preliminary work within our group suggests that a sequential dosing technique of permanganate pre-
oxidation can reduce competition by DOM. Sequential refers to the additional of fractional doses of 
permanganate over time as opposed to a single large dose. Kinetic models fitted to observational data 
of sequential dosing and singular dosing found that competition by DOM decreased with each 
sequential dose. In the presence of microbial DOM, sequential dosing increased MCLR removal and in 
the presence of terrestrial DOM sequential dosing decreased removal.  
A propidium Iodide (PI) staining assay was developed in order to quantify cell lysis cyanobacterial cells. 
This assay was validated with the Bioluminescence Assay using Vibrio fischeri. When the PI assay was 
used to quantify cell lysis of Microcystis cells, no significant cell lysis was observed using 10 ppm of 
potassium permanganate. Because of this, sequential dosing was tested using V. fischeri cells instead. 
Sequential dosing of permanganate in the presence of V. fischeri cells saw similar amounts of cell lysis 
when compared to a single dose of permanganate. This suggests that the rate of competition caused by 
cells does not change between doses of permanganate, unlike in the presence of DOM.  
The removal of MCLR by permanganate in the presence of both DOM and V. fischeri cells was estimated 
using a kinetic model. In only the presence of 5 mg/L of microbial DOM and 100 nM of MC, we predict 
one dose of 12 µM permanganate to remove 92% of MCLR after 40 minutes and two doses of 6 µM to 
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remove 99% of MCLR after 80 minutes. After adding competition by V. fischeri cells (optical density = 
0.44), removal by one and two doses of permanganate was predicted to decrease to 50% and 60% total 
MCLR removal, respectively.   
Our simulation suggests that the presence of both cells and DOM have the ability to significantly impact 
MCLR removal in the worst-case scenario. However, sequential dosing was expected to increase MCLR 
removal by 10%. This simulation assumed that the cells present would be V. fischeri, which is not 
representative of an actual cyanobacterial bloom. Additional work should be done to more carefully 
examine the cyanobacterial cells interactions with permanganate.  





General Introduction   
In recent decades, harmful algal blooms have become a growing concern in the Great Lakes and other 
Ohio waterways. HABS are composed of blue-green algae, or cyanobacteria, that can secrete toxic 
chemicals and deplete the nutrients and oxygen of a water body in a process called eutrophication. 
Eutrophication in lakes due to HABs is a result of excessive nutrient loading and favorable growing 
conditions caused by climate change. Rising water temperatures aid in the increasing severity of annual 
blooms (Steffan M. B., 2014). This means that the potential for additional cyanobacterial toxins 
increases as well, which would present a public health risk.   
The algal toxins of interest for this paper are Microcystins (MCs), specifically microcystin-LR (MCLR), one 
of the most well studied MC’s. MC’s are known hepatotoxins which can cause adverse health effects and 
potentially increase the risk of liver cancer when inhaled, absorbed through the skin, or ingested via 
drinking water (He, 2016). Many cities use lakes affected by harmful algal blooms as a source of drinking 
water therefore, it is important that publicly owned water treatment plants are prepared to treat source 
water that may contain high levels MCs. Although there is currently no federal maximum contaminant 
level (MCL) for MCs, the Ohio Environmental Protection Agency has set a health advisory for MCs as 1.6 
ppb. In the case of some municipalities, like the Celina Water Treatment Plant (Celina, Ohio), this can be 
a difficult concentration target to meet. Celina’s drinking water source is Grand Lake St. Mary’s (GLSM), 
which can contain levels of MC’s greater than 250 ppb during peak bloom conditions in the late summer 
(OEPA, 2020). In these extreme cases, POTWs will need to reach almost 100 percent removal of MCs, 




In a standard water treatment plant, cyanobacteria can be treated using coagulation and activated 
carbon. Coagulation has been shown to remove cyanobacteria cells, but not remove toxins (He, 2016). 
The presence of these cells and their metabolites can increase the amount of coagulant needed and 
disinfection byproduct formation, proving to be problematic (Moradinejad, 2019). The toxins can later 
be removed by powdered activated carbon (PAC) however, PAC can be expensive and although PAC 
physically removes toxins, they are not broken down into non-toxic byproducts (He, 2016). To effectively 
remove MCs to reach Ohio advisory levels, there is a need for additional alternative treatment methods.   
As a result of the effort to study algal toxin removal, many emerging treatment methods have been 
developed using physical, biological, and chemical processes. The physical processes include physical 
oxidation of MCs using ultra-violet (UV) and ultra-sonification (Ding, 2010)and biological treatment of 
MCs uses microorganisms to degrade MCs into non-harmful byproducts (Massey, 2020). This paper, 
however, will focus on chemical oxidation of MC. The specific treatment method studied will be 
chemical pre-oxidation using potassium permanganate (KMnO4).   
Chemical pre-oxidation involves adding an oxidant to the treatment plant’s intake as to remove any 
MC’s that may exist in the water before even entering the plant. This is done so that the MCs cannot 
cause issues for the other units further along in the treatment train. Permanganate is often used for pre-
oxidation because of its low cost and relative ease of operation. Using permanganate for chemical 
oxidation will be much less expensive than similar chemical oxidants, specifically ozone. Additionally, the 
equipment needed for permanganate oxidation is much less complex than the infrastructure needed for 
a UV or biological treatment facility. These factors make permanganate pre-oxidation a more accessible 
treatment alternative for smaller plants. Additionally, the Celina plant already uses permanganate in its 




Although it is useful for the purpose of removing MC’s, permanganate is non-specific in that it can react 
with other species in the water if present. Permanganate is known to have favorable reactions with 
other organic compounds, including dissolved organic matter that may exist naturally in the water or 
even the outer membrane of the cyanobacterial cells themselves. If these species co-exist with MC’s in 
the water being treated, their reactions with permanganate may be more favorable than the reaction 
between permanganate and MC’s. If MC oxidation is not the preferred reaction in the system, MC 
removal by permanganate will be less effective. Therefore, permanganate is susceptible to 
“competition” posed by other favorable organics in the water.  
Permanganate has been shown to provide a multitude of benefits for a water treatment plant, in spite 
of this competition. However, its ability to control cyanobacterial cells and their toxins must still be 
carefully assessed (He, 2016). In this paper, the efficacy of permanganate for HABs affected waters will 
be studied.    
Public Health Review 
 
Description of MCLR  
The general structures of MCs are important in assessing the toxicity of each compound and what may 
be the most effective treatment method. MCs are cyclic heptapeptides. The general structure includes a 
large ring which adds to the stability of the molecule. Attached to the ring and common to all MC 
variants is the adda moiety. Also on the ring are two positions for variable amino acids. There have been 
many different combinations of amino acids discovered which has resulted in over 200 different MC 
variants (Massey, 2020). For MCLR, these two positions are occupied by Leucine (L) and Arginine (R) 
(Figure 1). MCLR is a variant of MC that can be produced by many different cyanobacterial species, 




Figure 1: Structure of Microcystin-LR (Enzo Life Sciences, 2021) 
 
Mechanism of Toxicity   
 
There are several pathways of toxicity for MCs, most of which are consequences of initial inhibition of 
enzymes and oxidation stress. The specific enzymes targeted by MCLR are the protein phosphatases PP1 
and PP2A. MCLR’s alpha-carboxyl group of the D-glutamic acid and the adda moiety bind near the active 
site of the enzymes. The complete pathway for the adda’s interaction with the enzymes is complex and 
beyond the scope of this paper, however, it is important to note that the MC’s will become significantly 
less toxic after the adda has been oxidized. The hindrance of the active site inhibits enzymatic activity 
(Campos, 2010).  These enzymes are important to human health because they regulate protein activity 
through phosphorylation and dephosphorylation. Lack of activity from these enzymes could result in 
hyperphosphorylation of important proteins, hepatic hemorrhage, DNA damage, and other effects 
(Massey, 2020). Along with phosphorylation regulation, PP2A is considered to be a tumor suppressor, 
thus linking the change in its activity to cancer cell development (Campos, 2010).  MCLR has also been 
found to cause adverse health effects in the form of oxidative stress. MCLR can cause oxidative stress 
through MC mediated reactive oxygen species production (Campos, 2010). The production of ROS in 
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humans can trigger cellular apoptosis, damage DNA, and enhance cancer cells. The potential lack of 
PP2A tumor suppression and enhancement of cancer cells makes MCLR a possible carcinogen. Generally, 
there is no acceptable dose for a carcinogen, but studies have been performed to determine the effects 
of acute and chronic exposure to MCLR.  
In these studies, the oral LD50 was found to be 5000 ug/kg in mice, but there is not an experimental 
LD50 found for humans yet. The three leading pathways of human exposure to MCLR are consumption 
of contaminated food or water, bodily contact, and inhalation.  Humans can experience this chronic, 
low-dose exposure when source water with algal blooms is transported into public drinking water 
distribution systems. There have also been many documented events of human MC poisoning through 
drinking water systems affected by HABs. For example, a bloom of Microcystis in a drinking water 
reservoir contaminated the water supply for a hemodialysis center in Brazil in 1996. The acute exposure 
to MCs resulted in 131 patient casualties (Massey, 2020). Studies related to chronic, low dose exposure 
in humans found that the MCLR exposure resulted in alveolar collapse and lung cell apoptosis (Massey 
2020). With no federal legislation, there are many communities whose finished drinking water contains 
MC levels higher than the World Health Organization’s (WHO) recommended health advisory of 1 μg/L 
(ppb, ~ 1 nM). Even with a health advisory of 1 ug/L, some work suggests that chronic exposure events 
of 1 ug of MCLR can stimulate cancer cell migration (Zhang, 2011). In GLSM, MC levels can reach 
concentration greater than 100 ppb in the late summer. Constant monitoring of MC in GLSM by the Ohio 
EPA has consistently reported high concentrations for over a decade (OEPA, 2020). With the constant 
detection of MC in their source water, the residents of Celina are now at risk of chronic exposure to 
MCs. However, public exposure to MCLR can be prevented through the use of proper and effective 
drinking water treatment.    
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Permanganate pre-oxidation of MCLR  
Permanganate has the ability to serve many different roles in a drinking water treatment train. 
Permanganate is a strong oxidant with highly favorable reactions towards many types of organic 
compounds. Because of this, permanganate is used in drinking water treatment plants to remove 
organic contaminants like taste and odor compounds and micropollutants (He, 2016). It has even been 
shown to selectively react with many antibiotics (Hu, 2010). Permanganate is also effective when used 
as a disinfectant and can inhibit biological growth (He, 2016). For the purpose of this paper, 
permanganate’s most important function is its ability to remove algal toxins.   
The treatment method of interest in which permanganate is used to remove algal toxins is pre-
oxidation. Pre-oxidation refers to the addition of oxidants in the source intake of a water treatment 
plant. The intent is to remove as many algal toxins as possible before reaching the plant. As discussed 
earlier, MC’s can be problematic in other portions of the treatment train, so it is best that they are 
removed immediately (He, 2016).  Additionally, harmful algal blooms can be a season issue for 
treatment plants, so additional treatment for algal toxins may be more logistically feasible at the 
beginning of the treatment train.   
 
MCLR Oxidation Performance of other Oxidants   
 
The chemical structure of MCLR is also important in predicting how it may be oxidized by permanganate. 
MCLR contains 3 alkene groups (double bonds), two of which are on the adda moiety. Permanganate 
tends to preferentially react with (oxidize) alkenes, and the oxidation of the adda moiety significantly 
reduces the toxicity of MCLR (Szlag, 2019). This suggests that permanganate reduces MCLR 
concentrations by oxidizing the alkenes of the adda moiety. The products of this oxidation reaction are 
an organic product and manganese oxides (MnO2).  Plant operators may be concerned about the 
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production of manganese oxides because total manganese is regulated by the EPA. The organic by-
products of permanganate oxidation are significantly less toxic than MCLR and are no longer of concern. 
Many treatment plants, however, are hesitant to use permanganate as an oxidant because it is not as 
well researched compared to traditional oxidants, despite performing similarly with respect to MC 
removal.  
Many studies have been conducted to compare the performance of common pre-oxidation agents. One, 
conducted by Ding, 2010, compared the ability of several oxidants to remove 6 different MC variants 
and their ability to inactivate Microcystis aeruginosa cells. Permanganate's performance was compared 
to that of ozone, free chlorine, chlorine dioxide, and monochloramine. The study found that Microcystis 
aeruginosa cells were inactivated most effectively in the following order: ozone > permanganate ~= free 
chlorine > chlorine dioxide > monochloramine. This order also represents the oxidation efficiency of MCs 
by these oxidants. Although free chlorine and permanganate had similar oxidation rates for total MC’s, 
permanganate removed MCLR, MCRR, MCYR, and MCLA more effectively than free chlorine. For MCLR 
specifically, oxidation by permanganate was significantly faster than free chlorine. To achieve 100% 
MCLR removal (20 ug/L MCLR), free chlorine required a concentration times contact time five times 
greater than that needed by permanganate. The results of this study suggest that permanganate is 
suitable for pre-oxidation, as it was found to be an effective treatment for both MA inactivation and 
MCLR removal (Ding, 2010). This study (similar to many others) did not conduct experiments in “natural 
waters” (or water with DOM). However, DOM will be present in the surface waters being treated, so the 
interactions between KMnO4 and DOM will need to be examined.  
Competition between MCLR and DOM  
 
The presence of DOM in the source water is important because it can influence the performance of pre-
oxidation. Pre-oxidation using permanganate is affected by DOM because DOM can compete with MCLR 
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for permanganate reactions, causing a lower removal efficiency of MCLR removal (Laszakovits J. R., 
2019). If some of the permanganate is going to be consumed by DOM during oxidation, then it must be 
accounted for by increasing the concentration of the permanganate dose. This increase will cause a 
higher cost for materials needed and produce a higher MnO2 residual. In order to utilize our pre-
oxidation materials most effectively, it is important to understand the competition posed by organic 
matter.   
The reaction mechanisms between permanganate and organic compounds can aid as an explanation as 
to why DOM causes a significant amount of competition. DOM is a complex mixture of dissolved organic 
compounds that originates from the breakdown of natural matter like plants and bacterial cells, which 
will differ for each natural water system. Typically, DOM of natural waters exists along a spectrum of 
terrestrial (plant-like DOM) to algal (algal cell-like material). The variance in composition leads DOM 
mixtures to behave differently with respect to permanganate oxidation. For example, some work 
suggests that permanganate will react preferentially with natural organic matter that has a high 
molecular weight and is aromatic (Laszakovits J. R., 2020). This suggests that DOM mixtures with a 
significant portion of high molecular weight and aromatic compounds would likely present more 
competition than a mixture with a lesser portion of these types of compounds. Although there is a 
consensus in the literature that DOM can present competition during pre-oxidation with DOM, there is 
still some contention as to which compounds cause the most competition. In stark contrast to the 
conclusions drawn in the study by Laszakovits, a study done by Jeong et al, 2017 found that DOM with 
low molecular weight and low aromaticity were the greatest MCLR oxidation inhibitors (Jeong, 2017). In 
this paper, I will not examine the exact competition of DOM, but instead treat the mixtures as single 
entities.   
We can model MCLR removal using the rate of the MCLR/permanganate reaction and the DOM/ 
permanganate reaction, which is the competition reaction (Equation 1). This model, derived in 
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Laszakovits and MacKay, 2019, can predict MCLR concentration given the conditions of the system i.e., 
the MCLR/permanganate and DOM/permanganate reaction rates. In this model, kobs represents the 
observed rate constant in the reaction between DOM and permanganate. The competition rate constant 
(kobs) can be calculated using observational data of MCLR concentration changes during permanganate 
pre-oxidation. A high kobs value would indicate that the DOM/permanganate reaction is fast, presenting 
more competition than a low kobs value. Permanganate oxidation will be most efficient when kobs is 















Previous preliminary work in our group found that the kDOM of a particular water sample can change as 
additional doses of permanganate were added. This study found that the competition rate would 
decrease as additional doses were added, pointing to a possible solution for decreasing competition. So, 
a sequential dosing technique of permanganate was investigated. Sequential dosing refers to the 
addition of multiple doses of permanganate over a period of time, as opposed to the traditional method 
of a single dose of permanganate. In the study, permanganate was added to a solution containing both 
MCLR and DOM. After the reaction had stopped (the permanganate was consumed), a second, 
equivalent dose of permanganate was added to the same solution. The MCLR concentration was tracked 
during both doses. Although both doses of permanganate were equivalent in concentration and 
therefore should consume the same amount of DOM and MCLR, the second dose removed more MCLR 
than the first dose. This implies that competition presented by DOM may have decreased between the 
two doses. The decrease of DOM competition observed shows that sequential dosing could be a 
potential method to increase removal efficiency of MCLR. The general difference in MCLR removal 
16 
 
between a single large dose and sequential dosing is currently unknown but will be investigated in this 
paper.    
Cell lysis and the release of toxins  
 
Similar to DOM, cyanobacterial cells will also be present in source intake water, so the effect that these 
cells have on pre-oxidation treatment will also need to be investigated. Using strong oxidants like 
permanganate or chlorine will be useful in removing MC’s but may also attack the cells and cause 
oxidative stress. The presence of cyanobacterial cells pertinent to pre-oxidative treatment because we 
want to oxidize extracellular toxins without introducing new, intracellular toxins into the water. When 
the outer membrane of a microbial cell is compromised, cell lysis occurs. During lysis, the contents of 
the cell are released into solution. In the case of cyanobacteria, which can contain toxins inside of the 
cell membrane (intracellular toxins), cell lysis can cause these intracellular toxins to move outside of the 
cell (now extracellular toxins). The exact chemical pathway in which cell membranes are broken can be 
different for different oxidants and organisms. When E. coli was exposed to ozone, it was believed that 
ozone reacted with the lipid bilayer of the outer membrane, lysing the cells (Wert E. C., 2014). And when 
chlorine reacted with MA cells, the chlorine was shown to have reacted with the amines in the 
phospholipids of the outer membrane in order to damage cells Ramsier 2011 (Ramseier, 2011).   
Currently, literature suggests that permanganate does not cause a significant amount of cell lysis under 
typical treatment doses (<5 mg/L) but has the ability to do so using higher doses. Qu et al (2015) 
reported that less than 10% of MA cells lysed after exposure to 1.0 mg/L and 2.0 mg/L of potassium 
permanganate for 20 minutes (Qu, 2015). Fan et al (2013) reported similar results and that MA cell 
integrity will not be affected for potassium permanganate doses less than 3 mg/L (Fan J. ,., 2013). 
However, they did see that the percentage of intact cells was only 74% and almost 0% after 6 hours of 
exposure to 5 mg/L and 10 mg/L, respectively. Ou et al (2019) also found that doses of permanganate 
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less than 5 mg/L only caused little cell lysis (Ou, 2012). Doses greater than 5 mg/L did cause significant 
cell lysis, but only after at least 48 hrs.    
Permanganate’s ability to lyse cyanobacterial cells can be compared to that of other oxidants to 
determine if it is suitable for pre-oxidation treatment. There are existing studies comparing the effects 
that compare these oxidants with respect to cell lysis.  A study by Wert et al. In 2013 tested the degree 
to which MA cells would lyse after exposure to ozone, free chlorine, chlorine dioxide, chloramine. The 
study defined general cell damage as a loss of chlorophyll-a. Cell lysis was determined using flow 
cytometry (FCM). After lysis, the cells have fragmented into particles that are too small to be read on 
the FCM, and the particle counts by the instrument would report a concentration change in “alive” cells. 
All of the oxidants tested were shown to cause some degree of general cell damage, but the MA cells 
were most susceptible to lysing after exposure to ozone and chloramine. Although this study did not 
examine permanganate, it is still important to recognize that these common water treatment plant 
oxidants have the ability to damage cells, so any oxidant used during pre-oxidation could potentially 
release toxins through cell lysis (Wert E. C., 2013).   
The study by Ding et al (2010) discussed earlier in the paper also examined the effects of their suite of 
oxidants on MA cell lysis. This study did not measure cell viability concentrations of damage directly, but 
defined cell lysis as an increase of MCLR concentration. Oxidants were dosed into a solution with both 
cells and MCLR and the concentration of MCLR was measured throughout the reaction. Free chlorine, 
ozone, and permanganate did not show any buildup of MCLR. This does not mean that cells were not 
lysis because the cells were successfully inactivated, but it is possible that any additional MCLR that was 
released was also oxidized. Chlorine dioxide, however, did see cause a buildup of MCLR. This was 
because the rate of MCLR oxidation was not as fast as the rate of M-LR release by the cells (Ding, 2010). 
Based on these findings, some oxidants can be strong enough or dosed in such a high amount that they 
may cause cell lysis and simultaneously oxidize the now extracellular toxins. Because permanganate did 
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not cause an increase in MCLR after exposure to some doses, this “over-dosing” is a possible treatment 
method.  
A study by Wert, 2014 reported similar results. In this study, MCLR concentrations were measured after 
MA cells were exposed to ozone, free chlorine, chlorine dioxide, and chloramine at different 
concentrations. Oxidant doses lower than 0.63 mg/L experienced a positive change in MCLR 
concentration after oxidation. Oxidant doses (except for chloramine) greater than 0.63 mg/L saw no 
increase in MCLR, suggesting that any released MCLR was subsequently oxidized. The fact that lower 
doses of oxidant showed a positive increase in MCLR, and higher doses showed no MCLR buildup 
suggests that there is some threshold where the rate of MCLR oxidation exceeds the rate of intracellular 
toxin release (Wert E. C., 2014). Although this “over-dosing” technique eliminates the issue of MCLR 
release by cells, the excessive use of oxidants can potentially be a waste of resources and produce 
higher residuals in the case of permanganate, where total manganese is regulated. To determine how to 
more efficiently utilize our resources, we can further investigate the occurrence of cell lysis on the basis 
of each oxidant’s reaction with the cell membrane.    
A study by Ramseier 2011 examined the membrane damage of aquatic cell cultures native to Zurich, 
Switzerland after exposure to ozone, chlorine dioxide, chloramine, chlorine, ferrate, and permanganate. 
This study measured cell damage using a Sytox Green (SGI)/ Propidium Iodide (PI) staining method 
coupled with FCM. The staining method uses fluorescence to differentiate between live and dead cells, 
where live, undamaged cells will be SGI positive and PI negative. PI is a membrane impermeable 
molecule and a nucleic acid specific stain. Cells will only be stained with PI when their membranes are 
compromised enough to allow PI to enter the cell. Among the oxidants tested, chlorine was able to 
damage membranes at the lowest CT values and permanganate and chloramine required the highest CT 
values to damage cells (on the order of 100 mg*min/L). Ramseier suggested that the reaction of amine 
moieties plays an important role in membrane damage (Ramseier, 2011). Based on this study, 
19 
 
permanganate may be a more suitable candidate for pre-oxidation because it required the highest CT in 
order to lyse cells, which was likely due the difference in reaction mechanisms of cell damage when 
compared to chlorine-related oxidants.   
Measuring Cell Lysis  
 
An important distinction to make between the previously discussed studies was the way in which cell 
lysis was quantified. In this paper, I will also discuss results based on how cells have been lysed. Because 
cell lysis is difficult to directly measure, it is important to choose a cell lysis measurement method that 
can accurately convey the results of a specific experiment. One method used to quantify cell lysis is by 
directly measuring the contaminate of interest, MCLR. The central reason that we are concerned with 
cell lysis is due to the potential release of cyanotoxins, so measuring MCLR directly responds to that 
concern. However, MCLR measurement without any other measures of cell lysis leaves much to 
speculation. Measurements of MCLR cannot differentiate between toxins intentionally released by the 
cell and those unintentionally released through a broken membrane. Additionally, as observed in Ding 
2010 and Wert 2014, the rate of MCLR oxidation can exceed the rate of MCLR release, which makes it 
nearly impossible to determine how much MCLR was released by higher doses of oxidants.   
A similar method to measuring MCLR concentration is the measurement of dissolved organic carbon 
(DOC) before and after oxidation. In this method, cells that have been damaged by oxidation will release 
their intracellular organic matter (including their toxins), and the release of their organic components 
will show a positive change in DOC content (Wert E. C., 2014). In addition to being non-specific to 
cyanotoxins, my experiments will require a high concentration of background DOM. This background 
content may make it difficult to measure small changes in DOC due to cells.   
Cell lysis can also be interpreted through cell viability assays. The main concern with viability assays is 
that it can be difficult for them to differentiate between inactivated or “dead” cells with no membrane 
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damage and cells that not dead but have a somewhat damaged membrane. A study by Moradinejad, 
2019 highlights the discrepancy between MA cell viability and cell lysis. After oxidation by permanganate 
and others, cells were examined using flow cytometry (FCM), Scanning Electron Microscopy (SEM), and 
liquid chromatography with organic carbon and nitrogen detection (LC-OCD-OND). After permanganate 
oxidation, the total counts of cells did not change much, implying that no cell death/lysis had occurred, 
however, FCM of the same samples found that viability was actually much lower (between 15-60% 
viability) (Moradinejad, 2019). Information taken from these assays suggests that cells were inactivated 
and partially but not completely fragmented.  
For my experiments, I have chosen to use a PI staining assay for its potential to measure additive cell 
lysis. As mentioned earlier, PI is a membrane impermeable molecule, and will fluoresce when bound to 
nucleic acids. If a cell’s membrane has become compromised enough to the point that its DNA can be 
released from the cell, the PI will bind to this extracellular DNA. In this way, PI signal can be used as 
proxy for cell lysis where the fluorescence of a sample should positively correlate to the number of cells 
lysed (Stiefel, 2015). I have chosen PI staining as opposed to FCM because I do not need to examine the 
degree to which cells are damaged or their viability. This method will determine if cells are damaged 
“enough” to be stained with PI.   
Limitations of previous studies   
 
Permanganate tends to be missing among the oxidants tested in MCLR removal and cell viability studies. 
In the studies that do include permanganate, it tends to perform similarly too or better than chlorine in 
terms of MCLR oxidation. Several studies have shown that permanganate has the ability to lyse cells at 
certain doses, but typically causes less lysis than chlorine. The difference in cell lysis may be attributed 
to the difference in reaction mechanisms between the two. Permanganate's MCLR oxidation 
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performance and its lower rates of cell lysis (when compared to chlorine) suggest that it is a strong 
candidate for pre-oxidation.   
Other environmental factors can influence oxidant performance other than the specific oxidant species 
chosen. The morphology of cyanobacterial colonies and antibiotics pollution was shown to inhibit cell 
damage and increase MCLR release, respectively but this is far beyond the scope of this paper (Fan J. R., 
2016) (Liu, 2020). However, in the case of permanganate, DOM has been demonstrated to inhibit MCLR 
removal. This DOM will scavenge permanganate and can potentially impact the interactions between 
cells and permanganate.  There is a gap in literature with respect to how the presence of DOM and cells 
can affect MCLR oxidation and subsequent toxin release. Because both DOM and cyanobacterial cells 
will be present during pre-oxidation, there is a need to develop a treatment method that can mitigate 
the issues associated with both DOM competition and cell lysis.   
Overview of Thesis 
 
 In this paper, I will further examine sequential dosing and its effects on MCLR removal. Sequential 
dosing has been suggested to decrease competition caused by DOM between doses. It may be possible 
that this decrease in DOM competition will positively impact MCLR removal. Competition for 
permanganate reactions has been shown to differ between DOM compositions, so it was important to 
include different DOM isolates in our analysis. Sequential dosing has not been tested in the presence of 
cyanobacterial cells so its effects on cell lysis are unknown. Across all oxidants in the studies discussed 
earlier in this paper, bacterial cell lysis tends to positively correlate with oxidant dose, so that low 
oxidant doses typically cause less cell damage than larger doses. Sequential dosing involves the addition 
of multiple “small” doses of permanganate over a longer period of time as opposed to one large dose. 
Spreading the permanganate dose over time may prove to be a “gentler” treatment method for cells 
and result in less call damage. There is also a lack of data related to MCLR removal in the presence of 
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DOM and cyanobacterial cells. If sequential dosing of permanganate is used in this scenario, the 
decrease in competition DOM with each sequential dose may also impact the rate at which cells are 
lysed. I hypothesize that sequential dosing od permanganate will increase removal MCLR when 
compared to a single dose in the presence of both DOM and cyanobacterial cells.  
To test this hypothesis, I will need to establish rate constants for the reactions that permanganate has 
with MCLR, DOM, and cyanobacterial cells. First, I determined the second order rate constant between 
MCLR and permanganate and compare that to other rate constants reported in the literature. Then, 
observational data of MCLR removal was collected using sequential dosing in the presence of DOM. 
Sequential dosing was compared to an equivalent single dose of permanganate. The observational data 
was fitted to an equation that can determine the rate constant of DOM competition for that dose.   
To determine the rate at which permanganate will react with cyanobacterial cells, I developed a 
biological assay using propidium iodide (PI). The PI assay will show how cells lyse with respect to time 
and this lysis rate will be used as a proxy for the permanganate/cell reaction. Out of the interest of time, 
observational data of MCLR removal in the presence of DOM and cells could not be collected. However, 
I will conclude this paper by building a model to predict how MCLR may be removed in this scenario 
using the aforementioned rate constants.   
Research significance  
 
If sequential dosing is shown to improve MCLR removal in the presence of DOM and cyanobacterial 
cells, sequential dosing can serve as an accessible treatment method for drinking water treatment plants 
that experience seasonal or year-round harmful algal blooms. Additionally, sequential dosing can be 
easily implemented at plants that already use permanganate for pre-oxidation purposes. Sequential 
dosing may be the easiest to implement at water treatment plants that source water from the Great 
Lakes and transport the water miles inland. Two dosing points could be installed in between the plant 
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and the lake so that the plant would not have to manually increase the retention time to accommodate 
sequential doses. Most importantly, if successful, sequential dosing will improve MCLR removal while 
using the same amount of permanganate resources.   
 




Permanganate – MCLR rate constant   
Procedure  
The second order rate constant for the MCLR/permanganate reaction was determined using a pseudo-
first order kinetics method. A pH 7 buffer was made using solid monosodium phosphate to achieve a 
concentration of 5 mM of phosphate and adjusted using 1 M hydrochloric acid (HCl) and 0.1 M sodium 
hydroxide (NaOH). For each kinetic run, a 100 nM solution of microcystin-LR was made in pH 7 buffer. 
Then, potassium permanganate (between 1 µM and 3 µM) was added to the solution based on the 
desired half-life. Half-lives were estimated using the second order rate constant of 272 1/min as 
reported by Laszakovits and Mackay, 2019. As the reaction proceeded, 2 mL of sample were removed 
from the buffer-MCLR-permanganate solution every 6 minutes over the course of two half-lives. After 
the sample was pulled, it was quenched with 0.08 mM thiosulfate quencher to achieve a working 
concentration at least 10 times greater than the concentration of permanganate. Each quenched sample 
was filtered with 0.2 um nylon filters and discharged into an LC vial for analysis. The samples were then 
analyzed using ultra-high pressure liquid chromatography (UPLC) on Waters Aquity Class H UPLC. The 





Figure 2: UPLC calibration curve to determine MCLR concentration 
 
Data Analysis  
The second order rate equation for the reaction between permanganate and MCLR is shown in Equation 





=  −𝑘[𝐾𝑀𝑛𝑂4][𝑀𝐶𝐿𝑅] 
 
 



















Because the concentration of permanganate is in excess (at least 10 time greater than [MCLR]), the 
decay of MCLR can be converted into a pseudo-first order rate equation. In Equation 3, kobs is the 




=  −𝑘𝑜𝑏𝑠[𝑀𝐶𝐿𝑅] 
The linear form of the first order rate equation along with a linear regression was then used to 
determine the observed first order rate constant (Equation 4).   
Equation 4 
[𝑀𝐶𝐿𝑅]𝑡 =  −𝑘𝑜𝑏𝑠(𝑡) + [𝑀𝐶𝐿𝑅]0 
Removal of MCLR by Permanganate in the presence of DOM  
Procedure  
The competition rate constant of the DOM/permanganate using an experimental procedure similar to 
that used to determine the MCLR/permanganate second order rate constant. Organic matter solutions 
were made in the same pH 7, 5 mM phosphate buffer. Using either Suwannee River Fulvic Acid 
(terrestrial) or Grand Lake St. Mary’s (microbial) DOM isolates were added to the buffer to achieve 5 
mg-C/L. 100 nM microcystin-LR (MCLR) was added to the buffer/DOM solution. 5 mM potassium 
permanganate stock solution was added to 40 mL of the buffer/DOM/MCLR solution to achieve working 
concentrations of either 2, 3, 4, 6, or 12 µM of permanganate.   
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For each dose added in the same kinetic run, 7 timepoints were taken and each timepoint was either 6 
or 7 minutes apart (depending on the dose).  At each timepoint, a 2 mL sample of the 
permanganate/MCLR/buffer/DOM solution was pulled and quenched with 0.08 mM thiosulfate solution. 
Each quenched sample was discharged into an LC vial for analysis. Each separate dose of permanganate 
was allowed to react in solution for at least 40 minutes. The samples were analyzed using UPLC on a 
Waters Aquity Class H UPLC and MCLR concentrations were calculated using the calibration curve in 
Error! Reference source not found..   
Data analysis   
Equation 5 determines the concertation of MCLR at a given time using the second order permanganate/ 
MCLR rate constant, k, the observed first order permanganate/DOM rate constant, kDOM, the initial 
concentration of MCLR, and the initial concentration of permanganate (Laszakovits J. R., 2019). 
Experimental data of MCLR degradation from each separate dose of permanganate was fitted to this 
















Bioluminescence Assay and Propidium Iodide controls  
Procedure 
The propidium iodide cell lysis assay was validated using a bioluminescence assay. The bioluminescence 
assay (BLIA) was used with Vibrio fischeri according to the methods described Abbas et al, 2018 (Abbas, 
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2018). V. fischeri cultures were obtained from Dr. Natalie Hull at Ohio State University. A dose-response 
curve for luminescence of cells with respect to permanganate or copper sulfate exposure was created. 
Samples were analyzed in 96-well luminescence plates. Cell cultures of V. fischeri were prepared for the 
PI assay using the same experimental procedure as the BLIA. After cells were exposed to either copper 
sulfate or permanganate for at least 30 minutes in 96-well fluorescence plates, 1.5 mM of PI stock 
solution was added to each well to achieve a working concentration of 15 µM of propidium iodide. 
Samples were allowed to stand for at least 25 minutes for full formation of DNA-PI complex. The 
fluorescence of the samples was read with excitation of 490 nm and an excitation of 645 +/- 40 nm on a 
BioTek Synergy HTX multi-mode plate reader. The subsequent fluorescence - response curve was then 
compared to the luminescence response curve to validate the propidium iodide method.   
Data Analysis  
Equation 6 was used to determine the percentage of cells alive after 30 minutes of exposure to either 
copper sulfate or potassium permanganate where Li is the luminescence corresponding to some 
concentration of oxidant, i, and L0 is the luminescence of the negative control, when 100% of cells 






The percentage of cells alive as determined by the PI assay is shown in Equation 7. In this equation, PIi is 
the PI fluorescence signal corresponding to some concentration of oxidant, i, PI100% is the PI signal 
corresponding to the highest oxidant dose (when 100% of the cells are dead), and PI0 is the PI signal of 
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Sequential dosing – cells   
Procedure 
The propidium iodide assay was used to track the degree of cell lysis with respect to time during 
sequential dosing of permanganate. A cell preparation procedure similar to the one described in BLIA 
was used to prepare cells. Starter cultures of Microcystis aeruginosa were obtained from Nicholas 
Dugan, US Environmental Protection Agency, Water Infrastructure Division, Cincinnati OH. Either V. 
fischeri or Microcystis cells were diluted from their pure cultures and resuspended in 1X phosphate 
buffer solution (PBS). Then, 20 mL of prepared cell solution (OD 600 = approximately 0.44) was dosed 
with 5 mM permanganate stock solution to achieve working concentrations between 12.6 µM (2 ppm) 
and 63 µM (10 ppm). Additional permanganate was added to the same reaction solution in the case of 
sequential doses. Approximately 10 time points were taken during every 40-minute dose as the reaction 
proceeded. At the specified time point, the solution was plated in 96-well plated and quenched with 2.6 
mM Thiosulfate to achieve a working concentration of 433uM. After all samples were quenched, 1.5 
mM of PI stock solution was added to each well to achieve a working concentration of 15 µM of 
propidium iodide. Samples were allowed to stand for at least 25 minutes for full formation of DNA-PI 
complex. The fluorescence was then read on the BioTek Synergy HTX multi-mode plate reader using the 
485/20 excitation filter and 645/40 excitation filter. The positive control for these experiments was 
solution of cells (OD600 = 0.44) that was exposed to 83 µM of permanganate for 30 minutes, then was 
quenched with 2.6 mM of Thiosulfate to achieve a working concentration of 433 µM. Based on results 
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from the BLIA, the positive control will represent 100% of the cells lysed. 15 µM of PI was also added to 
the positive control and allowed to stand for at least 25 minutes before its fluorescence was read. The 
background fluorescence was determined using a negative control containing only PBS and 15 µM of PI.   
Data Analysis  
A slightly modified version of Equation 6 was used to determine the percentage of cells lyses after 
exposure to permanganate with respect to time. In Equation 8, PI100% is the PI signal of the positive 
control, which represents a reading where 100% of the cells have lysed, PI0 is the PI signal at time zero 




𝑃𝐼100% − 𝑃𝐼0 
 
The degradation of permanganate was estimated using the cell lysis curve from Equation 8. At some 
point during exposure to permanganate, the reaction appeared to stop when the differences in PI signal 
readings became statistically insignificant. This was typically around 14 minutes. I assumed that at this 
point, all of the permanganate had been consumed. It was also assumed that the permanganate 
degradation was proportional to the total percentage of cells removed. Equation 9 estimates the 
permanganate concentration at time t using this relationship where tend is the time where the reaction 
between permanganate and cells has ended, PA0 is the percentage of cells alive at time zero, Pt,end is the 








) ∗ [𝐾𝑀𝑛𝑂4]0 
Results and Discussion 
 
KMnO4/MCLR rate constant   
We have determined the second order rate constant of the permanganate/MCLR reaction to be 282 
1/M*sec (+/- 39 1/M*sec) (Figure 3). This is generally consistent with other reported rate constants. 
Laszakovits and MacKay 2019 reported a rate constant of 272 1/sec*M (+/- 23). Rodriguez et al, 2007 
reported a rate constant of 357.2 +/- 17.5 1/Ms. 
 
Figure 3: Second order rate constant for reaction between permanganate and MCLR determined between relationship between 
observed rate constants and permanganate dose 
























MCLR/ Permanganate kinetics in presence of DOM    
Sequential dosing versus a singular dose of permanganate was tested in 5 mg/L DOC of either SRFA or 
GLSM DOM isolates (Figure 4 a-f.).   
 
 
Figure 4:  A through C, sequential dosing of 12 µM of permanganate total separated into either 1, 2, or 3 does in 5 mg/L DOC 
SRFA phosphate buffer (pH 8). E through F, sequential dosing of 12 µM of permanganate total separated into either 1, 2, or 3 
does in 5 mg/L DOC GLSM phosphate buffer (pH 8). On each individual plot are the kobs (kDOM) values for each dose (in 1/min). 
Solid lines on each plot are the theoretical values for MCLR degradation used in Equation 5. 
SRFA  
For those experiments conducted in the presence of SRFA isolate, the rate of DOM competition 
decreased with each sequential dose. For two doses of 6 µM, kDOM decreased from 0.41 to 0.03 1/min 
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and for three doses of 4 µM, kDOM decreased from 0.52 to 0.10 to 0.04 1/min. However, this decrease in 
competition did not lead to an improvement in MCLR removal as we had anticipated. Between one dose 
of 12 µM, two doses of 6 µM, and three doses of 4 µM, MCLR removal increased from 96% to 91% and 
86%, respectively. This may be attributed to the negative correlation between the concentration of the 
first dose and the observed competition rate. The observed kDOM of one dose of 12 µM was 0.05 1/min, 
while the first dose of 6 µM experienced a competition rate almost 10 times greater. The initial 
competition rate also increased between 6 µM and 4 µM, but only from 0.41 to 0.52 1/min. For both of 
the dosing methods that used sequential dosing, the subsequent doses showed a competition rate 
similar to the competition rate experienced by the first dose of a single dose. For instance, the 
competition rate of the second dose of 6 µM is approximately 8% of the initial competition rate and the 
second dose of 4 µM is approximately 19% of the initial competition rate. Between the second and third 
doses of 4 µM, the competition rate decreased by 60%. This is still a substantial decrease in competition 
rate, but not as great as the difference between the first and second doses. This suggests that the initial 
competition from DOM is the biggest “hurdle” when using pre-oxidation in the presence of SRFA DOM.   
GLSM  
Similar to those experiments conducted in SRFA buffer, the competition rate in the presence of GLSM 
isolate buffer also decreased with each sequential dose. Between two doses of 6 µM, the rate of 
competition decreased from 0.04 to 0.02 1/min, and between three doses of 4 µM, the rate of 
competition decreased from 0.11 to 0.04 to 0.03 1/min. Unlike the SRFA, MCLR removal increased with 
the number of doses used from 92% to 96% to 97% with one, two, and three doses, respectively. There 
was also not any trend in the initial competition rate for the first dose of each experiment. However, for 
those sequential dosing experiments, the initial kDOM was much lower in the presence of GLSM than in 
the presence of SRFA.   
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This is likely due to the differences in composition between the two DOM isolates. Permanganate has 
been shown to preferentially react with aromatic DOM compounds, which are positively correlated to 
both SUVA254 and electron donating capacity (Laszakovits J. R., 2020). GLSM and SRFA DOM were 
measured to have SUVA254 values of 1.23 and 4.83, respectively. SRFA’s higher SUVA254 value suggests 
that its increased competition stems from a higher aromaticity than GLSM. GLSM isolate is derived from 
a lake that often experiences intense algal blooms and is considered to be more microbial cell related 
DOM and SRFA is more terrestrial or plant DOM.  Because of this, we can assume that the DOM present 
during an algal bloom will behave similarly to the GLSM isolate.   
BLIA/Propidium iodide verification  
The dose-response curves of the bioluminescence assay (BLIA) using both copper sulfate and potassium 
permanganate are shown in Figure 5. For copper sulfate, samples had near zero luminescence readings 
by 31 µM and for permanganate, samples had near zero values with approximately 100 µM. A 
luminescence reading of zero would indicate that all of the cells are at least non-viable. Based on the 
dose response curve, permanganate was able to damage all of the cells, although it required much 




Figure 5: BLIA Dose-response curve for Vibrio fischeri cells after exposure to either 0-63 µM of copper sulfate or 0-126 µM of 
permanganate for 30 minutes   
 
With only the BLIA dose response curve, it is difficult to determine how the cells have become non-
viable. They may have been fully lysed or just significantly damaged. The propidium iodide dose 
































Figure 6: Propidium Iodide Dose-response curve for Vibrio fischeri cells after exposure to either 0-63 µM of copper sulfate or 0-
126 µM of permanganate for 30 minutes 
  
Using the PI assay, the highest fluorescence values occurred using the highest dose of either oxidant, 
which is also when the lowest luminescence readings occurred. So, at these points, the cells are all no 
longer viable (according to the BLIA) and each oxidant has reached its maximum PI signal. Again, with 
only these two assays, it is impossible to know if 100% of the cells have lysed, but the general agreeance 
between the maximum scalar fluorescence values achieved by both copper sulfate and permanganate 
suggests that this is the maximum amount of cell lysis that can occur. For the remainder of this study, 
we will assume that the maximum lysis is the same as 100% of the cells lysing.   
Using both assays, their readings have been normalized to represent cell viability curves (Figure 7 and 
Figure 8).  For both copper sulfate and permanganate, the viability curves generated with the BLIA and 






















compromised enough to have been dyed by PI are also non-viable cells. The agreement between these 
two assays means that the PI assay can be used to track cell lysis of bacterial cells that do not also bio-
luminesce (I.e., cyanobacteria).   
 
 






























Figure 8: Percentages of cells alive after exposure to 0-126 µM of potassium permanganate for 30 minutes as determined by 
both BLIA and PI Assays 
  
PI Assay with Microcystis Cells  
 
The PI cell lysis assay was then tested using Microcystis aeruginosa (MA) cells. The positive control in 
this assay was a sample of MA cells that have went through three freeze-thaw cycles, which is thought 
to completely lyse MA cells (USEPA, 2021). As shown in Figure 9, samples were exposed to 63 μM (10 
ppm) of permanganate and no significant cell lysis was observed. Additionally, when the same 
experiment was conducted using Vibrio fischeri, the signal of the V. fischeri positive control was 
approximately 48,000 and the MA positive control was approximately 21,000 while both negative 
controls (only non-lysed cells and PI) had similar values of approximately 20,000 when read in the same 






























Figure 9: Percentage of Microcystis cells alive versus time after exposure to 63 μM (10 ppm) of potassium permanganate 
The difference in PI signal between the two organisms can be a result of many reasons. V. fischeri may 
contain more genetic material for PI to stain compared to MA cells. The low PI signal of the positive 
control supports suggests that at this concentration of MA cells, a fully lysed sample does not contain 
much genetic material to be observed. Concentrations of the cells were determined using optical 
density, so the cell-count-to-optical-density relationship may also be different between the two.   
The low PI signals may also suggest that MA cells are somewhat resistant to permanganate in terms of 
cell lysis. Our results agree with findings in the literature. Many studies have found that significant cell 
lysis of MA cells did not occur for doses of permanganate less than 5 mg/L. Additionally, much longer 
contact times were needed to observe significant lysis (>6 hours). Therefore, typical treatment doses of 
permanganate (< 3 mg/L) should not be expected to cause a significant amount of cell lysis. Additional 
work should be done using the PI assay to confirm that significant MA cell lysis does not occur during the 
























Sequential dosing with Cells   
Sequential dosing of 5 ppm as potassium permanganate was tested in 1 X PBS with V. fischeri (OD600 = 
0.44). Between one dose of 5 ppm and two doses of 2.5 ppm, we did not observe any significant 
difference in cell death (Figure 10). In both cases, approximately 45% of cells were viable after oxidation.   
 
 
Figure 10: Percentage of cells alive versus time after exposure to either one dose of 5 ppm potassium permanganate (31.5 µM) 
or two doses of 2.5 ppm potassium permanganate (15.75 µM) 
Our results indicate that cell lysis caused by one dose will be similar to that caused by sequential dosing. 
The similarity between the performance of a singular dose and sequential doses of permanganate 
suggests that the reaction rate between sequential doses is not changing enough to affect the number 
of cells lysed. Although we did not observe any significant effects with cell lysis rate immediately after 
























Cells competition rate constant  
Using fundamental rate equations, the observed reaction rate between permanganate and V. fischeri 
cells was determined for each dose. Equation 10 is the second order reaction rate between the cells and 




=  −𝑘[𝐶𝑒𝑙𝑙𝑠][𝐾𝑀𝑛𝑂4] 
 
 
After using doses permanganate upwards of 63 µM (10 ppm KMnO4, which are unrealistically high in a 
typical treatment setting), permanganate would not cause 100% cell lysis. So, there was not a scenario 
in which the cells were the limiting reactant in this reaction. Because of this, we can assume that the 




=  −𝑘𝑐𝑒𝑙𝑙𝑠[𝐾𝑀𝑛𝑂4] 
                                                      
Equation 11 is the pseudo first order rate of decay of permanganate, where kcells is the observed first 
order rate constant.  Using the cell viability data shown in Figure 10, the permanganate degradation of 
each dose was estimated based on when the reaction “stopped.” The reaction was determined to have 
stopped after the observed cell viability became consecutively statistically insignificant, or 
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concentrations showed no further change with time. This was typically around 14 minutes after 
exposure to permanganate. At this point, we assumed that all of the permanganate was consumed.   
Then, kcells was determined for each dose using the linearized first order rate equation (Equation 12). In 
this equation, [KMnO4]0 is the initial concentration of permanganate and [KMnO4]t is the estimated 
remaining concentration of permanganate at time t. [KMnO4]t was estimated by assuming that all 
permanganate had been consumed approximately 14 minutes after the addition of each dose and the 
consumption of permanganate was proportional to the total number of cells degraded. A linear 
regression was then used to determine kcells.   
Equation 12 
ln[𝐾𝑀𝑛𝑂4]𝑡 =  −𝑘𝑐𝑒𝑙𝑙𝑠 ∗ 𝑡 + ln[𝐾𝑀𝑛𝑂4]0 
Figure 11 shows the kcells for a dose of 5 ppm of permanganate in potassium permanganate. For this 
dose, kcells was determined to be 0.199 1/min +/- 0.023 1/min. For the first and second doses of 2.5 ppm, 
their kcells values were 0.273 1/min (+/- 0.68 1/min) and 0.265 1/min (+/- 0.018 1/min), respectively. 
Although there was a slight decrease in the kcells between the two doses, this decrease is only 
approximately 3%. This aids the suggestion that the competition posed by the cells is not dramatically 




Figure 11: Natural log of estimated potassium permanganate remaining (µM) versus time to determine the observed rate 
constant between permanganate and V. fischeri cells 
 
Full Simulation  
In order to simulate MCLR removal in the presence of DOM and cells, the remaining permanganate must 
be estimated while accounting for consumption by MCLR, DOM, and the cells. The rate of MCLR decay is 
shown on Equation 2. The rate of permanganate degradations can be seen in Equation 13. In this model, 



































Both rates of MCLR decay and permanganate decay can be expanded into a numerical solution made up 
of two coupled differential equations. Equation 14 and Equation 15 determine the concentrations of 
MCLR and permanganate at each time step based on the conditions of the previous time step.   
Equation 14 
[𝑀𝐶𝐿𝑅]𝑡+1 = [𝑀𝐶𝐿𝑅]𝑡 + (−𝑘[𝐾𝑀𝑛𝑂4]𝑡[𝑀𝐶𝐿𝑅]𝑡) ∗ 𝑑𝑡  
Equation 15 
[𝐾𝑀𝑛𝑂4]𝑡+1 = [𝐾𝑀𝑛𝑂4]𝑡 + (−𝑘[𝐾𝑀𝑛𝑂4]𝑡[𝑀𝐶𝐿𝑅]𝑡 − 𝑘𝐷𝑂𝑀[𝐾𝑀𝑛𝑂4]𝑡 − 𝑘𝑐𝑒𝑙𝑙𝑠[𝐾𝑀𝑛𝑂4]𝑡) ∗ 𝑑𝑡   
 
This model aims to simulate a “worst case” scenario, with a high content of both MCLR and cells, 
simulating an intense bloom. The initial conditions include 100 nM of MCLR and 5 mg/L DOC of GLSM 
DOM isolate. The organism being simulated in this model is V. fischeri, where the solution should have a 
starting optical density of approximately 0.44. V. fischeri was simulated as opposed to Microcystis 
because our lysis data related to MA cells was inconclusive when compared to data collected using V. 
fischeri cell, which indicated lysis after exposure to permanganate. Figure 12 demonstrates the expected 
MCLR degradation using one dose of 12 µM and two doses of 6 µM of permanganate in the presence of 






Figure 12: Expected MCLR removal by one dose of 12 µM and two doses of 6 µM of permanganate. Dotted lines are the 
expected removal curves in the presence of DOM (5 mg/l DOC of GLSM isolate). Solid lines are the represented removal curves of 
MCLR in the presence of both DOM and V. fischeri cells (OD600 = 0.44) 
  
The MCLR and permanganate second order rate constant used was 272 1/sec (Laszakovits J. R., 2019). 
The kDOM values used in this simulation were pulled from experimental results, so the kDOM of the one 
dose of 12 µM was 0.07 1/min and the kDOM values for the first and second doses of 6 µM were 0.04 and 
0.02 1/min, respectively. The kcells values for each dose were estimated by using a linear regression for 
the relationship between the concentration of permanganate and the experimental kcells, like those 
determine in Figure 13.Using this, the kcells value of one dose of 12 µM was estimated to be 0.22 1/min, 
and the kcells value of both doses of 6 µM was estimated to be 0.20 1/min, assuming that the 
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Figure 13: Rate constant between 12 μM and 6 μM of cells estimated using observed relationship between permanganate dose 
and observed rate constant  
 
Our simulation predicts that, in the presence of DOM only, one dose of 12 µM of permanganate will 
remove approximately 92% of the total MCLR and two doses of 6 µM will remove approximately 99% of 
the total MCLR. These predictions are similar to our previous experimental results (Figure 4). In the 
presence of both DOM and cells however, we predicted that one dose of 12 µM of permanganate will 
remove 50% of the total MCLR and two doses of 6 µM will remove 58% of the total MCLR.    
 
The decrease in MCLR removal for both a single dose and sequential doses shows that the competition 
for permanganate reactions caused by cells has the potential to severely impact treatment 
performance. With the addition of cells into the system, we predict MCLR removal to decrease by 
approximately 40% of the total MCLR.  This dramatic decrease in performance may be due to the 
difference in average competition rates for both DOM and cells. For all three doses of permanganate, 
























the kDOM was less than 0.10 1/min and the kcells was at least 0.20 1/min or greater. So, competition 
caused by the cells was at least twice as great as the competition caused by the cells. In the case of the 
second dose of 6 µM of permanganate, kDOM was less than one tenth that of kcells.   
 
The difference between MCLR removal simulated with and without consideration for cells may be 
attributed to the relatively high cell density. With an optical density of V. fischeri of 0.85, the sample is 
cloudy with cells, so this may be unrealistically high for even an intense bloom. Additionally, the cells 
used in this simulation were not cyanobacteria, which may behave differently in the presence of 
permanganate. Based on our data, it is unclear how quickly permanganate was consumed by MA cells. 
There is a need to more closely monitor the consumption of permanganate by MA cells to determine its 
competition rate. Based on the mathematical model that runs the simulation, whatever the kcells value 
may be, MCLR removal will be less than in the presence of only DOM as long as kcells is nonzero. This is 





• Sequential dosing is an alternative dosing technique for permanganate pre-oxidation 
where the same amount of permanganate is used, but fractional portions of the total 
permanganate are added over time as opposed to all at once.  
• Competition by DOM decreases with each dose of permanganate when using sequential 
dosing. 
• Sequential dosing may increase MCLR removal in microbial-like DOM but may decrease 
MCLR removal in terrestrial DOM when compared to removal using a single dose of 
permanganate.  
• Sequential dosing predicted to improve MCLR removal in the presence of 
V. fischeri and microbial-like DOM. 
 
Future Work 
• Experimental data should be collected to examine how MCLR is removed in the 
presence of environmentally relevant concentrations of both DOM and cyanobacterial cells   
• More work should be done using the propidium Iodide assay with MA to determine the 
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Potassium Permanganate – Arcos Organics Potassium Permanganate CAS 7722-64-7 
MCLR – Enzo Life Sciences Microcystin-LR ALX-350-012-C100 suspended in 1 mL in methanol  
Grand Lake St. Mary’s DOM isolate – Isolated by Carissa Hipsher using solid phase extraction 
Suwannee River Fulvic Acid DOM isolate – purchased from International Humic Substances Society 
Solid Mono Sodium phosphate – Fisher Chemical Sodium Phosphate Monobasic Monohydrate CAS 
10049-21-5 
Solid Sodium Thiosulfate – Fisher Chemical Sodium Thiosulfate Pentahydrate CAS 10102-17-7   
1M HCl  
1 M NaOH 
1XPBS – Phosphate buffered Saline powder pH 7.4 (Pcode: 1003127976) 
Photobroth – 38719 Sigma-Aldrich Photobacterium broth, pH 7.0 +/-0.2 (Pcode:  
Propidium Iodide – Biotium Propidium Iodide 1mg/mL solution in water 
Solid Copper Sulfate – Fisher Chemicals 
Water – Mili-Q 
 
Instruments 
UPLC - Waters Acquity Class H UPLC 
Plate reader – BioTek Synergy HTX multi-mode reader 
 Excitation Filter 485/20 - Biotek 
 Emission Filter 645/40 - Biotek 
UV-Vis – Agilent Cary Series UV-Vis Spectrophotometer 
TOC – Shimadzu TOC-V CSN Total Organic Carbon Analyzer 
Fluorometer – Cary Eclipse Fluorescence Spectrometer  
 
Organisms  
Vibrio fischeri pure culture – Natalie Hull, Ohio State University  
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Microcystis aeruginosa pure culture – Nicholas Dugan, US Environmental Protection Agency, Water 
Infrastructure Division, Cincinnati OH 
 
Other Materials  
MicroSolv nylon 0.2 μM syringe filters  
 
Appendices  
Appendix A  
 
Propidium Iodide Controls Read on Fluorometer 
 
 
Figure 14: Emission spectra of Propidium Iodide (15 μM) in solutions of V. fischeri cells (OD600 = 0.44, in 1X PBS) after exposure 






Figure 15: Emission spectra of Propidium Iodide (15 μM) in solutions of V. fischeri cells (OD600 = 0.44, in 1X PBS) after exposure 





Figure 16: Maximum intensity of Propidium Iodide (15 μM) Signal vs. time after V. fischeri cells (OD600 = 0.44, in 1X PBS) were 






Figure 17: Raw fluorescence data from plate reader. Propidium Iodide (15 uM) signal of V. fischeri cells (OD600 = 0.44, in 1X PBS) 
after exposure to either 10 ppm (63 µM) or 5 ppm (31.5 µM) of KMnO4. “100%” control represents cells exposed to 83 µM of 
KMnO4 for 30 mins. “Blank” refers to 1X PBS only.  
 
 
Appendix B – MATLAB Code  
Main Code – MCdsing_new.m 
 
clear all  
clc  
  
%MC DOSING CODE NEW  
%this program will be used to analyze the data using cell structures  
  
  
%convert excel sheets to cell array using MCxl2cell function  
MCD = MCxl2cell('MCdosingSumConc.xlsx', 'MCdosingERRORS.xlsx'); 
  
  
%             exp1         exp2         exp3       ... 
%  dose 1   [6x8 array]  [6x8 array]   [6x8 array] 
%  dose 2   [6x8 array]  [6x8 array]   [6x8 array] 
%  dose 3   [6x8 array]  [6x8 array]   [6x8 array] 
  
%within each 6x8 array  






















Vibrio fischeri with 5 and 2.5 ppm of KMnO4 in 1 XPBS
10 ppm 5 ppm Dose 1 5 ppm Dose 2
Blank + PI "100 %" cells + PI
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%Col 2= time (min) 
%Col 3= KMnO4 dose (mM) 
%Col 4= [MC-LR] in nM (ppb) 
%Col 5= Standard Deviations (errors) in ppb 
%Col 6= Dose added time (min) 
%(these two rows will be added later in code)  
%Col 7= kobs (1/min) (to be added) 
%Col 8= "theoretical" [MC-LR] based on kobs (ppb) (to be filled in)  
  
%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% k observed values %%%%%%%%%%%%%%%% 
  
%create placeholder vector matrix for kobs values  
[rows, cols] = size(MCD);  
  
kobs_mat = zeros(3, cols);  
  




%% Find k observed of each dose  
  
for d = 1:1:3 
    for e = 1:1: NumExp 
     
        t = (MCD{d,e}(:,2))-(MCD{d,e}(1,6)); %col 6 of each cell is 
DOSE TIME vector 
        %must subtract the  
        %so that t_1 = 0  
        conc = MCD{d,e}(:,4); %col 4 of each cell is [MC] vector  
        MnO4 = MCD{d,e}(1,3); %col 3 of each cell is [MnO4] vector 
        %only need the first value of the vector though  
         
        if d ==1  
            %if it is the 1st dose, the initial value will be the 1st 
[MC] 
            %measurement  
            MC_int = MCD{d,e}(1,4); %Initial [MC] is the first element 
in the [MC] vector 
        else 
            %Initial [MC] value will be the last measured [MC] value 
of the 
            %previous dose 
             
            %in some doses, the last [MC] value of the previous dose 
is 
            %NaN... if thats the case, we need to use NEXT to last 
value 
            %from previous dose as MC0 
             
            if isnan(MCD{d-1,e}(end,4)) 
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                MC_int = MCD{d-1,e}(end-1,4) 
                 
            else 
             
            MC_int = MCD{d-1,e}(end,4); 
             
            end 
                      
             
        end 
             
             
             
        [fitresult,gof] = kobscurvecode(t, conc, MnO4, MC_int); 
     
        kobs_mat(d,e) = coeffvalues(fitresult); 
     
    end %end e loop 
     
end %end d loop  
  




%% assign kobs values  
  
%assign first value in the last column of each cell as the k observed 
for 
%that dose  
  
for e = 1:1:NumExp 
    for d = 1:1:3 
        MCD{d,e}(1,7) = kobs_mat(d,e); 
         
    end %end d loop 
     
end %end f loop  
  
  





for e = 1:1:NumExp  
    for d = 1:1:3 
        %calc a value at every timepoint  
        for k = 1:1:length(MCD{d,e}(:,1)) 
             
            %define variables  
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            time = (MCD{d,e}(k,2))- (MCD{d,e}(1,6)) ; %col 2 is time 
vector 
            %must subtract time of dose (from column 6) 
            MnO4_0 = MCD{d,e}(1,3); %col 3 is MnO4 dose  
            kobs = kobs_mat(d,e); %kobs will be the same for every 
timepoint in one dose 
             
                if d ==1  
                     %if it is the 1st dose, the initial value will be 
the 1st [MC] 
                     %measurement  
                     MC_0 = MCD{d,e}(1,4); %Initial [MC] is the first 
element in the [MC] vector 
                else 
                    %Initial [MC] value will be the last measured [MC] 
value of the 
                    %previous dose 
             
                    MC_0 = MCD{d-1,e}(end,4); 
             
                end 
             
             %plug in variables to get theoretical concentration     
             MCD{d,e}(k, end) =  TheoMCconc(time, MnO4_0,kobs, MC_0); 
              
        end %end k loop  
         
    end %end d loop  
     
end %end e loop  
  
%% PLOTTING %%%%%% 
  
  
%%  12 v 6 v 4 uM in SRFA and GLSM 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
  





















title('4 uM x 3 Doses in SRFA') 
hold off 
  




title('12 uM x 1 Dose in GLSM') 
hold off 
  




title('6 uM x 2 Doses in GLSM') 
hold off 
  




title('4 uM x 3 Dose in GLSM') 
hold off 
  
%%  6 v 3 v 2 uM in SRFA and GLSM 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
  
%6 uM in SRFA (mannualy plot) 
  
subplot(2,3,1);  
t1 = MCD{1,21}(:,2);  
MC1 =  MCD{1,21}(:,4); 
Th1 =  MCD{1,21}(:,8); 
scatter(t1, MC1, 20, 'ko', 'filled');  
hold on 
%Plot Theoretical Values of dose 1 
plot (t1, Th1, 'r'); 
%errors 
errorbar(t1, MC1, MCD{1,21}(:,5) ,'LineStyle', 'none'); 
legend ('Dose 1') 
  
title('6 uM x 1 Dose in SRFA') 
  
xlabel('Time (min)'); 






kobs1 = strcat('kobs Dose 1 =  ', num2str(MCD{1, 21}(1,7), '%.2f'), 
'(1/min)'); 
  
 perc_rem = MC1(1)-MC1(end);  
    percent = strcat('Percent Removal =  ', num2str(perc_rem, '%.0f'), 
'%'); 
    txt = {kobs1, percent}; 
    text(50,50, txt) 
hold off 
  




title('3 uM x 2 Doses in SRFA') 
hold off 
  




title('2 uM x 3 Doses in SRFA') 
  











t1 = MCD{1,25}(:,2);  
MC1 =  MCD{1,25}(:,4); 
Th1 =  MCD{1,25}(:,8); 
scatter(t1, MC1, 20, 'ko', 'filled');  
hold on 
%Plot Theoretical Values of dose 1 
plot (t1, Th1, 'r'); 
%errors 
errorbar(t1, MC1, MCD{1,25}(:,5) ,'LineStyle', 'none'); 
legend ('Dose 1') 
  
title('6 uM x 1 Dose in GLSM') 
  
xlabel('Time (min)'); 






kobs1 = strcat('kobs Dose 1 =  ', num2str(MCD{1, 25}(1,7), '%.2f'), 
'(1/min)'); 
  
 perc_rem = MC1(1)-MC1(end);  
    percent = strcat('Percent Removal =  ', num2str(perc_rem, '%.0f'), 
'%'); 
    txt = {kobs1, percent}; 









title('3 uM x 2 Doses in GLSM') 
hold off 
  













title('12 uM x 1 Dose in GLSM') 
hold off 
  




title('6 uM x 2 Doses in GLSM') 
hold off 
  














%Find average kobs values  
  
%5 mg/L of SRFA %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
  
%initialize parameters  
  
sums = zeros(5,3); 
counts = zeros(1,5); 
  
%count the number of each types of doses 
  
for i = [ (14:1:24),36,38];  
     
    if MCD{1,i}(1,3) == 12 
         
         counts(1) = counts(1) +1; 
         
    elseif MCD{1,i}(1,3) == 6 
         
        counts(2) = counts(2) +1; 
         
    elseif MCD{1,i}(1,3) == 4 
         
        counts(3) = counts(3) + 1; 
         
    elseif MCD{1,i}(1,3) ==3  
         
        counts(4) = counts(4) +1; 
         
    else MCD{1,i}(1,3) == 2 
         
        counts(5) = counts(5) +1;  
         
    end  
end 
     
  
%% sum up kobs values of each dose type  
  
  
for i = [ (14:1:24),36,38];  
     
    for k = [1 2 3] 
     
         if MCD{k,i}(1,3) == 12; 
              
             sums(1,k) = sums(1,k) + MCD{k,i}(1,7); 
              
         elseif MCD{k,i}(1,3) == 6; 
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             sums(2,k) = sums(2,k)+ MCD{k,i}(1,7);  
              
         elseif MCD{k,i}(1,3) == 4; 
              
             sums(3,k) = sums(3,k) +MCD{k,i}(1,7);  
              
         elseif MCD{k,i}(1,3) == 3; 
              
             sums(4,k) = sums(4,k) +MCD{k,i}(1,7);  
              
         else MCD{k,i}(1,3) == 2; 
              
             sums(5,k) = sums(5,k) + MCD{k,i}(1,7);  
              
         end 
    end 
end 
  
%% percent removals  
  
percremov = zeros(1, length([14:1:24,36,38])) 
percremovavg = zeros(1,5); 
  
for i = [ (14:1:24),36,38];  
     
    if MCD{1,i}(1,3) == 12 
         
         percremov(i) = MCD{1,i}(1,4)- MCD{1,i}(end,4); 
         percremovavg(1) = percremovavg(1) + percremov(i); 
          
    elseif MCD{1,i}(1,3) == 6 
         
        percremov(i) = MCD{1,i}(1,4)- MCD{2,i}(end,4); 
        percremovavg(2) = percremovavg(2) + percremov(i); 
         
    elseif MCD{1,i}(1,3) == 4 
         
        percremov(i) = MCD{1,i}(1,4)- MCD{3,i}(end,4); 
        percremovavg(3) = percremovavg(3) + percremov(i); 
         
    elseif MCD{1,i}(1,3) ==3  
         
        percremov(i) = MCD{1,i}(1,4)- MCD{2,i}(end,4); 
        percremovavg(3) = percremovavg(3) + percremov(i); 
         
    else MCD{1,i}(1,3) == 2 
         
        percremov(i) = MCD{1,i}(1,4)- MCD{3,i}(end,4); 
        percremovavg(2) = percremovavg(2) + percremov(i); 
         






%% avg values  
  
  
kobsavgdose1 = sums(:,1)'./counts;  
  
kobsavgdose2 = sums(:,2)'./counts; 
  
kobsavgdose3 = sums(:,3)'./counts;  
  
  
SRFAavgKobs = [kobsavgdose1; kobsavgdose2; kobsavgdose1];  




%% perc remove in GLSM 
  
percremovg = zeros(1, length([25:1:35,37])) 
percremovavg = zeros(1,5); 
  
for i = [25:1:35,37];  
     
    if MCD{1,i}(1,3) == 12 
         
         percremovg(i) = MCD{1,i}(1,4)- MCD{1,i}(end,4); 
         percremovavg(1) = percremovavg(1) + percremovg(i); 
          
    elseif MCD{1,i}(1,3) == 6 
         
        percremovg(i) = MCD{1,i}(1,4)- MCD{2,i}(end,4); 
        percremovavg(2) = percremovavg(2) + percremovg(i); 
         
    elseif MCD{1,i}(1,3) == 4 
         
        percremovg(i) = MCD{1,i}(1,4)- MCD{3,i}(end,4); 
        percremovavg(3) = percremovavg(3) + percremovg(i); 
         
    elseif MCD{1,i}(1,3) ==3  
         
        percremovg(i) = MCD{1,i}(1,4)- MCD{2,i}(end,4); 
        percremovavg(3) = percremovavg(3) + percremovg(i); 
         
    else MCD{1,i}(1,3) == 2 
         
        percremovg(i) = MCD{1,i}(1,4)- MCD{3,i}(end,4); 
        percremovavg(2) = percremovavg(2) + percremovg(i); 
         










Determining DOM competition rate constant – kobscurvecode.m  
function [fitresult, gof] = createFit(time, MC_conc, MnO4_0, MC_int) 
%CREATEFIT(TIME,MC_CONC) 
%  Create a fit. 
% 
%  Data for 'kobz' fit: 
%      X Input : time 
%      Y Output: MC_conc 
%  Output: 
%      fitresult : a fit object representing the fit. 
%      gof : structure with goodness-of fit info. 
% 
%  See also FIT, CFIT, SFIT. 
  
%  Auto-generated by MATLAB on 04-Mar-2020 12:11:56 
  
  
%% Fit: 'kobz'. 




%convert from number to string  
  
MC_int = num2str(MC_int); 
  
%Convert MnO4 dose to string  
  
MnO4_0 = num2str(MnO4_0);  
  
%Concatinate input variables into fitted equation  
  
% Set up fittype and options. 
ft = fittype( strcat(MC_int,'*exp(-272*60*1e-6*',MnO4_0,'*((exp(-
kobs*x)/-kobs)+(1/kobs)))'),'independent', 'x', 'dependent', 'y' ); 
opts = fitoptions( 'Method', 'NonlinearLeastSquares' ); 
opts.Algorithm = 'Levenberg-Marquardt'; 
opts.Display = 'Off'; 
opts.StartPoint = 1e-5; 
  
% Fit model to data. 




% Plot fit with data. 
figure( 'Name', 'kobz' ); 
h = plot( fitresult, xData, yData ); 
legend( h, 'MC_conc vs. time', 'kobz', 'Location', 'NorthEast' ); 





Theoretical MCLR concentration Calculations – TheoMCconc.m 
 
function [theo_val] = TheoMCconc(time, MnO4_0,kobs, MC_0) 
  
%function that finds the theoretical MC_t in the competition model 
based on 
%time (min), MnO4- conc (M), the K_obs(1/min), and the initial MC conc 
for 





Load in Data from excel – MCx12cell.m  
 
function [NewCell] = MCxl2cell(MCdatasheet, MCerrsheet) 
  
% This function will combine the two excel sheets used in MCdosing.m 
into a 
% cell array similar to the one used in AltDosingMC.m  
%enter the names of the excel sheets as strings  
%MCdatasheet = excel sheet w MC concentration values  
%MCerrsheet = excel sheet w stdev data for error bars  
  
  
%% read sheet and form arrays  
%Read main data sheet  
MC_d = readtable(MCdatasheet);  
  
%read error data sheet  
MC_e = readtable(MCerrsheet);  
  
%convert both tables to arrays  
MC_d = table2array(MC_d);  
MC_e = table2array(MC_e);  
  
  
%first column of MAIN data array is time vector, exclude this vector 
time = MC_d((2:1:end),1);  
68 
 
MC_d = MC_d(:, 2:1:end);  
  
%First row of the MAIN data array contains the [pmgnt] vector 
%extract the row and then exclude it  
  
pmgnt = MC_d(1, :);  
  
MC_d = MC_d(2:1:end, :);  
  
  
%% Create cell array  
  




[row, col] = size(MC_d);  
  
%each experiment will contain 8 columns of data  
%Col 1= dose # 
%Col 2= time (min) 
%Col 3= KMnO4 dose (uM) 
%Col 4= [MC-LR] in nM (ppb) 
%Col 5= Standard Deviations (errors) in ppb 
%Col 6= Dose added time (min) 
%(these two rows will be added later in code)  
%Col 7= kobs (1/min)  
%Col 8= "theoretical" [MC-LR] based on kobs (ppb) 
  
NewCell = zeros(row, col*8);  
  
%% Place data in array  
  
%first create dose # vector  
  
one = ones(1,6);  
two = 2*one; 
three = 3*one; 
dosenum = [one, two, three]; 
  
%use another index that will multiply by k after every iteration  
%initialize h  
h = 1; 
  
for k = 1:1:col 
     
    %input dose number 
    NewCell(:, h) = dosenum' ; 
    %time vector (min)  
    NewCell(:, h+1) = time' ;  
    %KMnO4 dose (uM)  
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    NewCell(:, h+2) = pmgnt(k)*ones(1,row)'; %pmgnt will be the same 
in each element of the vector  
    %MC-LR data in nM 
    NewCell(:,h+3) = MC_d(:, k); %k is the "exp number" 
    %stdev data  
    NewCell(:, h+4) = MC_e(:, k);  
    %dose added time  
    NewCell(:,h+5) = [zeros(1,6), 40*ones(1,6), 80*ones(1,6)]'; %for 
these experiments, all of the doses will have been 
    %added at the same times  
     
    %seventh and eight rows in this iteration are intentionally left 
blank  
     
    %add 8 to h to go to next set of rows  
     
    h = h+8;  





%% partition into cells  
  
%separate vertically into 3 groups of 6 rows each  
%separate horizontally into "col" groups of 8 columns each  
NewCell = mat2cell(NewCell, [6 6 6], [(8*ones(1,col))]); 
  
  
%% Convert non-existant doses to zero vectors  
%12 uM exps only have 1 dose  
%6 and 3 uM exps only have 2 doses  
%4 and 2 uM exps have all three doses  
%converting to zero vectors is makes using plotting functions easier  
  
[row, col] = size(NewCell); 
  
for i = 1:1: row 
    for j = 1:1: col  
     
        if NewCell{i,j}(1,4) == 0  
             
            NewCell{i,j} = zeros(1,8); 
             
        end 











Plot Experiments – AltDosePlot.m  
 
function AltDosePlot (Cell_array, ExpN) 
%Plotting function to plot a single experiment from the "Alternate 
Dose 
%Timing" experiments  
%The input cell array "Cell_array" will always have 3 rows of cell, 1 
for 
%each dose 
%ExpN = Experiment #, referencing particular column of the cell array 
  
%Each cell within the array will have 7 columns and various row 
numbers 
  
%Col 1= dose # 
%Col 2= time (min) 
%Col 3= KMnO4 dose (mM) 
%Col 4= [MC-LR] in nM (ppb) 
%Col 5= Standard Deviations (errors) in ppb 
%Col 6 = Dose time (min)  
%Col 7 = kobs (1/min)  
%Col 8 = "theoretical" [MC-LR] based on kobs (ppb) 
  
%% Assign Variables for each dose  
  
%Dose 1  
  
D1 = Cell_array{1,ExpN}; 
  
t1= D1(:, 2)'; %time vector  
p1 = D1(1,3); %KMnO4 dose 
MC1 = D1(:, 4)'; %[MC-LR] vector 
Er1 = D1(:, 5)'; %errors vector 




D2 = Cell_array{2,ExpN}; 
  
t2= D2(:, 2)'; %time vector  
p2 = D2(1,3); %KMnO4 dose 
MC2 = D2(:, 4)'; %[MC-LR] vector 
Er2 = D2(:, 5)'; %errors vector 
Th2 = D2 (:, 8)'; %Theoretical [MC] vector  
  
%Dose 3  
  




t3= D3(:, 2)'; %time vector  
p3 = D3(1,3); %KMnO4 dose 
MC3 = D3(:, 4)'; %[MC-LR] vector 
Er3 = D3(:, 5)'; %errors vector 
Th3 = D3 (:, 8)'; %Theoretical [MC] vector  
  
%% what buffer?  
  
if ExpN<= 6  
    buffname = ' in SRFA'; 
else 
    buffname = ' in GLSM'; 
     
end 
  
%% Compostite vectors based on number of non-zero doses in the exp 
  
if D2(1,1) == 0 
    %both doses 2 and 3 dont exist  
    time = [t1]; 
    MC_conc = [MC1]; 
    Errors = [Er1]; 
     
elseif D3 == 0 
    %Dose 3 is a zero dose and doesnt exist  
    time = [t1 t2]; 
    MC_conc = [MC1 MC2]; 
    Errors = [Er1 Er2]; 
         
    else 
    %There is a third dose  
    time = [t1 t2 t3]; 
    MC_conc = [MC1 MC2 MC3]; 
    Errors = [Er1 Er2 Er3]; 
     
end 
        
      
%% Plots  
  
%Plot raw data of first dose 
scatter(t1, MC1, 20, 'ko', 'filled');  
hold on  
  
  
if D3(1,1) ~= 0  
     
    %Plot raw data of second dose 
    scatter(t2, MC2, 20, 'k^', 'filled'); 
     
    %Plot raw data of third dose 
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    scatter(t3, MC3, 20, 'ks', 'filled'); 
     
    %Plot Theoretical Values of dose 1 
    plot (t1, Th1, 'r'); 
     
    %Plot Theoretical Values dose 2  
    plot ([D2(1,6),t2], [TheoMCconc(0,p2,D2(1,7), D1(end, 4)),Th2], 
'g', 'LineWidth', 2); 
  
  
    %Plot Theoretical Values dose 3 
    plot ([D3(1,6),t3], [TheoMCconc(0,p2,D3(1,7), D2(end, 4)),Th3], 
'c', 'LineWidth', 2); 
  
elseif D2(1,1) ~= 0 
    %Plot raw data of second dose 
    scatter(t2, MC2, 20, 'k^', 'filled'); 
     
    %Plot Theoretical Values of dose 1 
    plot (t1, Th1, 'r'); 
     
    %Plot Theoretical Values of dose 3 
    plot ([D2(1,6),t2], [TheoMCconc(0,p2,D2(1,7), D1(end, 4)),Th2], 
'g', 'LineWidth', 2); 
  
else 
    %Plot Theoretical Values of dose 1 
    plot (t1, Th1, 'r'); 
     
end 
  
%Add error bars to each dose  





%Determine if 3rd dose plot is needed  
if D3(1,1) ~= 0  
    
    legend ('Dose 1', 'Dose 2', 'Dose 3') 
    %title  
    title (strcat(num2str(D1(1,3)), strcat('uM KMnO4 x 3 doses', 
buffname))) 
elseif D2(1,1) ~=0 
  legend ('Dose 1', 'Dose 2')  
  title (strcat(num2str(D1(1,3)), 'uM KMnO4 x 2 doses', buffname)) 
   
else 
    title (strcat(num2str(D1(1,3)), 'uM KMnO4 x 1 dose', buffname)) 





%Axes + Axes Labels 
  
xlabel('Time (min)'); 




%% additional info 
  
kobs1 = strcat('k_{DOM} Dose 1 =  ', num2str(Cell_array{1, ExpN}(1,7), 
'%.2f'), '(1/min)'); 
kobs2 = strcat('k_{DOM} Dose 2 =  ', num2str(Cell_array{2, ExpN}(1,7), 
'%.2f'), '(1/min)'); 
kobs3 = strcat('k_{DOM} Dose 3 =  ', num2str(Cell_array{3, ExpN}(1,7), 
'%.2f'), '(1/min)'); 
  
if D3(1,1) ~= 0  
  
    perc_rem = MC1(1)-MC3(end); 
    percent = strcat('Percent Removal =  ', num2str(perc_rem, '%.0f'), 
'%'); 
    txt = {kobs1, kobs2, kobs3, percent}; 
      
    text(80,65, txt) 
  
elseif D2(1,1) ~= 0  
     
    perc_rem = MC1(1)-MC2(end); 
    percent = strcat('Percent Removal =  ', num2str(perc_rem, '%.0f'), 
'%'); 
    txt = {kobs1, kobs2, percent}; 
     
    text(60, 50, txt) 
      
  
else 
     
    perc_rem = MC1(1)-MC1(end);  
    percent = strcat('Percent Removal =  ', num2str(perc_rem, '%.0f'), 
'%'); 
    txt = {kobs1, percent}; 
    text(50,20, txt) 
     
     
end 
  
  
hold off 
end 
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